New combo therapy targets tough stomach cancer with liver spread
NCT ID NCT07602140
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a mix of treatments—including targeted therapy, immunotherapy, chemotherapy, and procedures that block blood flow to tumors or burn them—as a first treatment for people with a specific type of stomach cancer (HER2-high) that has spread to the liver. About 40 participants will receive this combination to see how well it shrinks tumors and delays cancer growth. The goal is to find a more effective first-line option for this hard-to-treat condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Disitamab vedotin, sintilimab, and chemotherapy drugs
What this could lead to
If it works, this could offer a new first-line treatment option for people with HER2-high gastric cancer that has spread to the liver, potentially shrinking tumors and delaying disease progression.
What could go wrong
This is an early-phase, single-arm study with only 40 participants, so results may not apply broadly. The combination of multiple treatments also raises the risk of serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER WITH LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••